Ruxolitinib salvage therapy is effective for steroid-refractory graft-versus-host disease in children: A single-center experience
- Vedat Uygun
- , Gülsün Karasu
- , Hayriye Daloğlu
- , Seda Öztürkmen
- , Suar Çakı Kılıç
- , Koray Yalçın
- , Safiye Suna Çelen
- , Volkan Hazar
- , Akif Yeşilipek
Research output: Contribution to journal › Article › peer-review
34
Citations
(Scopus)